What Is Transient Ischemic Dilation?

Transient ischemic dilation, or TID, is an apparent enlargement of the heart’s left ventricle on stress imaging compared to rest imaging, and it serves as a warning sign that the heart muscle may not be getting enough blood.¹ It typically shows up during a nuclear stress test, a common exam that uses small amounts of radioactive tracer to map blood flow through the heart at rest and under stress. The finding often points to significant coronary artery disease, though the picture is more nuanced than that simple link suggests.

Why the Heart Appears to Grow

During a nuclear stress test, images are taken of the heart twice: once at rest and once after stress (either exercise or a drug that mimics exercise). In a healthy heart, the left ventricle looks roughly the same size in both sets of images. When TID is present, the cavity of the left ventricle looks bigger on the stress images than on the rest images. The word “transient” is key here, because the ventricle is not permanently enlarged. The apparent size difference shows up only in the comparison between the two imaging sessions.

Researchers have described two main explanations for this phenomenon. The first involves the inner lining of the heart wall, the subendocardium. When severe coronary artery disease limits blood flow, the subendocardium is the first layer to suffer during stress. It picks up less radioactive tracer than the outer layers, so on the stress image it blends into the cavity, making the cavity look larger than it really is. At rest, blood flow recovers to the inner layers, and the cavity appears its true size again. The second explanation is that the left ventricle actually does dilate temporarily after stress because it struggles to pump effectively under the increased demand.² Both mechanisms can operate at once, and separating them in a given patient is not straightforward.

A particularly tricky scenario is balanced ischemia. If all three major coronary arteries are equally narrowed, the perfusion images can look deceptively normal because every region of the heart is underperfused by the same degree. No one zone stands out as worse than the rest. TID may be the only clue on the scan that something serious is going on, because the subendocardial effect described above still makes the cavity appear larger during stress.³

How It Is Measured

TID is expressed as a ratio: the volume of the left ventricular cavity on stress images divided by the volume at rest. A ratio of 1.0 means the cavity looks the same size under both conditions. Ratios above a certain cutoff are flagged as abnormal. Software packages built into the imaging workstation trace the inner wall of the heart automatically and calculate this ratio from the three-dimensional image data.⁴

This sounds simple, but the “normal” cutoff depends heavily on which imaging protocol, which radiotracer, which camera, and which software package was used. There is no single universal number that separates normal from abnormal. In one study using a pharmacological stress agent called regadenoson, the threshold was set at 1.39, which yielded very high specificity (about 95%) but low sensitivity (about 15%) for identifying patients with blockages in multiple coronary arteries.⁵ Other studies using different protocols have proposed cutoffs ranging from about 1.19 to 1.23 for standard ungated measurements.⁶ The lesson for patients: the ratio on your report has to be interpreted in the context of the specific protocol your lab used, not against some universal benchmark.

Some centers also look at gated measurements, where the camera captures the heart at specific moments in its beating cycle. From gated images you can separately calculate TID using end-diastolic volume (when the heart is most relaxed and filled) or end-systolic volume (when the heart is most contracted). Combining these volumes in different weighted formulas has been explored as a way to squeeze more diagnostic information out of the ratio, though the standard ungated approach remains the most widely used in clinical practice.⁷

What TID Tells Doctors About Coronary Disease

TID is generally treated as a marker of severe or extensive coronary artery disease. It tends to have high specificity, meaning that when the ratio is elevated, the chance it is a false alarm is relatively low. But it also has low sensitivity for less-severe disease, so a normal TID ratio does not rule out narrowed arteries.² Think of it as a finding that, when present, raises the alarm considerably, but its absence provides limited reassurance.

The relationship between TID and actual plaque buildup gets murkier when the rest of the perfusion images look normal. One study compared patients who had TID but no visible perfusion problems against a control group with neither TID nor perfusion defects, then imaged both groups with coronary CT angiography to look directly at plaque and narrowing. The researchers found no significant differences in plaque burden, calcium score, or the presence of blockages greater than 50%.⁸ In other words, TID without any accompanying perfusion abnormality did not predict worse atherosclerosis in that cohort. This suggests that an isolated TID finding on an otherwise clean scan may not always mean large-vessel coronary disease is lurking.

TID Without Blockages and Microvascular Disease

If TID is present but the big coronary arteries look fine, what is happening? One increasingly recognized explanation is coronary microvascular dysfunction, a condition where the tiny blood vessels that branch off the main arteries cannot dilate properly under stress. The subendocardium depends heavily on these small vessels, and when they malfunction, the same pattern of reduced inner-wall blood flow can appear on imaging.⁹

Long-standing high blood pressure and diabetes are two conditions frequently linked to isolated TID. Chronic hypertension thickens the heart muscle, which increases the pressure needed to push blood all the way through to the innermost layers. During stress, this mismatch between supply and demand becomes more pronounced. Diabetes damages small blood vessels throughout the body, including those in the heart wall. A study of patients with type 2 diabetes found that about half had an abnormal TID index, and TID correlated strongly with elevated levels of endothelin-1, a molecule the body produces in response to damaged blood vessel linings.¹⁰ That link supports the idea that in diabetic patients, TID reflects microvascular injury rather than large blockages in the coronary arteries.³

Predicting Future Heart Events

Beyond diagnosis, TID carries prognostic weight. In a study of patients with diabetes, adding TID to a statistical model that already included age, prior heart attack, pumping function, and ischemia significantly improved the ability to predict cardiac death or nonfatal heart attack. The adjusted hazard ratio was 3.6, meaning patients with an abnormal TID had roughly three and a half times the risk compared with similar patients who did not show TID.¹¹

More recent data from PET imaging (a newer and higher-resolution technique) reinforced the finding. A large analysis showed that for every 0.1-unit increase in the TID ratio, the risk of cardiac death rose by about 25%, and this held true whether or not the perfusion images showed abnormalities.¹² The fact that TID retained its predictive power even in patients with normal-looking perfusion underscores a point clinicians often stress: perfusion images alone do not capture the full picture. TID adds a layer of risk information that the tracer-uptake maps may miss.

In a PET study using rubidium-82, patients who were TID-positive but had no regional perfusion defects had significantly lower overall survival compared to those who were TID-negative. TID was an independent predictor of death, on par with having a severely reduced pumping fraction.¹³

Does Treating the Blockages Help?

When TID points to severe coronary disease, the natural question is whether opening the blocked arteries improves outcomes. In the diabetes study mentioned above, coronary revascularization (stenting or bypass surgery) had a pronounced effect on event-free survival in patients with TID. The interaction between revascularization and TID was statistically significant, suggesting that patients who had both TID and evidence of ischemia derived meaningful benefit from having blood flow restored.¹¹ This is an important practical point: TID may help identify patients who stand to gain the most from interventional treatment, potentially guiding decisions about who should proceed to catheterization.

For patients whose TID seems linked to microvascular dysfunction rather than large-vessel disease, the clinical path is different. There are no stents to place in tiny vessels. Management tends to focus on aggressive control of blood pressure, blood sugar, and cholesterol, along with medications that improve blood vessel function. Some centers have started using coronary CT angiography as a complementary test to help sort out whether a patient with TID and an otherwise normal perfusion scan has hidden large-vessel disease or is dealing with a microvascular issue instead.¹⁴

Technical Factors That Change the Numbers

One of the frustrations with TID is that the ratio is sensitive to the technical details of the test. Different radioactive tracers behave differently in the body, and this affects the measurement. A small study of female patients found that when rest images were obtained with thallium (an older tracer) and stress images with technetium-based sestamibi, TID ratios were significantly and artificially elevated. When the rest scan was redone with sestamibi, ratios fell back to normal. The likely explanation is that thallium images have more scatter, which distorts the apparent cavity size, and smaller hearts (more common in women) are more susceptible to this artifact.¹⁵

Camera technology also matters. Newer cadmium-zinc-telluride (CZT) cameras have higher sensitivity and resolution than older conventional SPECT cameras, which means the normal thresholds established on older equipment do not automatically transfer. Large registries have worked to derive camera-specific, tracer-specific, and protocol-specific upper limits of normal so that labs using newer equipment can interpret TID correctly.¹⁶ CZT cameras can also image patients in an upright position, and TID measured in the upright position has been shown to associate with extensive coronary disease, serving as a useful supplement to perfusion scoring.¹⁷

Software differences add another variable. A comparison using PET imaging with nitrogen-13 ammonia found that TID values differed depending on whether Corridor 4DM or Cedars-Sinai QPET software processed the images. Both packages detected higher TID in patients with ischemia, but only one of the two found statistically significant differences across all measurement methods.¹⁸ The practical takeaway is that a TID ratio generated at one facility using one software suite is not directly comparable to one generated elsewhere with a different setup.

Sex Differences in TID

Whether men and women need different normal thresholds has been debated. One study using same-day sestamibi imaging found no significant difference in TID ratios between men and women, and concluded that a single set of thresholds could be applied to both sexes.⁶ But another study that applied attenuation correction, a technique that adjusts for the absorption of radiation by surrounding tissue, found that women had slightly higher mean TID values than men, and the upper normal limit was 1.31 for women versus 1.18 for men.¹⁹ Breast tissue can attenuate the signal more in women, and smaller average heart size may amplify small differences in cavity-edge detection. The inconsistency between studies likely reflects differences in protocols and patient populations, but it reinforces the need for labs to validate their own normal ranges rather than borrowing published cutoffs wholesale.

TID in the Age of PET and Artificial Intelligence

PET imaging offers higher resolution than traditional SPECT and can quantify blood flow in absolute terms (milliliters per minute per gram of heart tissue), which SPECT cannot do reliably. TID measured by PET carries similar diagnostic and prognostic meaning to SPECT-based TID, but the normal thresholds are different. In one rubidium-82 PET study, the mean TID ratio in healthy reference patients was 0.98, and the abnormal threshold was set at greater than 1.13.¹³ That threshold is substantially lower than the cutoffs often used in SPECT, which underscores that the numbers are not interchangeable between technologies.

Artificial intelligence is beginning to fold TID into broader diagnostic models. A multicenter study across four sites used an AI model that integrated ten image-derived parameters from cardiac PET, including the TID ratio, coronary calcium score, ejection fraction, and myocardial blood flow, to diagnose obstructive coronary artery disease. By combining all of these metrics rather than interpreting any single one in isolation, the model aimed to improve diagnostic accuracy beyond what traditional reading can achieve.²⁰ TID’s role in that model as one piece of a larger puzzle reflects how clinicians are increasingly thinking about it: not as a standalone verdict, but as a variable that gains power when combined with other indicators of heart health.

For patients, the move toward multiparametric and AI-assisted interpretation means that a single number on a report is less likely to drive major decisions on its own. An elevated TID ratio will still prompt attention, but the clinical response will increasingly depend on whether the rest of the data, including flow measurements, pumping function, calcium burden, and symptom profile, paints a consistent picture or tells a more ambiguous story.